Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
- PMID: 17909452
- DOI: 10.1097/gme.0b013e318157ac70
Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
Comment on
-
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.Menopause. 2007 Nov-Dec;14(6):978-84. doi: 10.1097/gme.0b013e318054e2e7. Menopause. 2007. PMID: 17595593 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical